Kennedy Capital Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $628K | Buy |
55,702
+2,109
| +4% | +$23.8K | 0.02% | 535 |
|
|
2025
Q1 | $541K | Buy |
53,593
+685
| +1% | +$6.91K | 0.01% | 577 |
|
|
2024
Q4 | $626K | Buy |
52,908
+9,801
| +23% | +$116K | 0.01% | 628 |
|
|
2024
Q3 | $497K | Buy |
43,107
+6,194
| +17% | +$71.5K | 0.01% | 636 |
|
|
2024
Q2 | $390K | Buy |
36,913
+10,717
| +41% | +$113K | 0.01% | 651 |
|
|
2024
Q1 | $276K | Buy |
+26,196
| New | +$276K | 0.01% | 682 |
|